Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang-Yi Lo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Industrial Health|October 5, 2020
Early intervention mechanism for preventing electrocution in construction engineeringYau-Ren Shiau, Fang-Yi Lo, Po-Cheng Ko
Health Care Management Review|November 2, 2006
Benefiting from networks by occupying central positions: an empirical study of the Taiwan health care industryTzu-Ju Ann Peng, Fang-Yi Lo, Chin-Shien Lin, et al.
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Developmental Biology|October 13, 2009
FoxD5 mediates anterior-posterior polarity through upstream modulator Fgf signaling during zebrafish somitogenesisHung-Chieh Lee, Wei-An Tseng, Fang-Yi Lo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2012
Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancerFang-Yi Lo, Hsiung-Ting Chen, Hung-Chi Cheng, et al.
BMC Cancer|June 14, 2012
The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridizationFang-Yi Lo, Jer-Wei Chang, I-Shou Chang, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
American Journal of Respiratory and Critical Care Medicine|September 27, 2016
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase InhibitorsI-Shou Chang, Shih Sheng Jiang, James Chih-Hsin Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Industrial Health|October 5, 2020
Early intervention mechanism for preventing electrocution in construction engineeringYau-Ren Shiau, Fang-Yi Lo, Po-Cheng Ko
Health Care Management Review|November 2, 2006
Benefiting from networks by occupying central positions: an empirical study of the Taiwan health care industryTzu-Ju Ann Peng, Fang-Yi Lo, Chin-Shien Lin, et al.
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Developmental Biology|October 13, 2009
FoxD5 mediates anterior-posterior polarity through upstream modulator Fgf signaling during zebrafish somitogenesisHung-Chieh Lee, Wei-An Tseng, Fang-Yi Lo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2012
Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancerFang-Yi Lo, Hsiung-Ting Chen, Hung-Chi Cheng, et al.
BMC Cancer|June 14, 2012
The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridizationFang-Yi Lo, Jer-Wei Chang, I-Shou Chang, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
American Journal of Respiratory and Critical Care Medicine|September 27, 2016
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase InhibitorsI-Shou Chang, Shih Sheng Jiang, James Chih-Hsin Yang, et al.
Pageof 1